CADTH is pleased to announce the successful collaborators of its inaugural Post-Market Drug Evaluation (PMDE) Network. Collaborators will bring additional expertise to the PMDE Network and will respond to decision-makers’ queries by providing expertise and evidence in the post-market space.
The PMDE Program issued a request for proposals on March 15, 2022, for its Contractors. Proposals were reviewed by a multidisciplinary review panel that identified the following applicants to be PMDE Network Collaborators:
These collaborators bring decades of experience in the post-market landscape and are well prepared to respond to the needs of federal, provincial, and territorial decision-makers.
The PMDE Program will launch September 1, 2022, and contracts will be issued to these individuals or teams as queries are received by the PMDE Program.
If you have any questions about the PMDE Program or Network, please contact infoPMDE@CADTH.ca.